CPINV Care Property Invest NV
Care Property Invest NV is a Public Regulated Real Estate Company under Belgian law. The Company has been listed on Euronext Brussels for 30 years and invests in high quality healthcare real estate for elderly and disabled people on the European market. Care Property Invest purchases, builds and renovates high quality healthcare real estate, fully tailored to the needs of the end user and then makes it available to solid healthcare operators on the basis of a long-term contract. The Company is developing an international portfolio of healthcare projects, which currently counts 160 projects, spread across Belgium, The Netherlands, Spain and Ireland. The market capitalisation of Care Property Invest amounted to approximately 514 million euro on 12/08/2026. The Company aims to create a stable share for its shareholders with a low risk profile and a stable and steadily growing dividend. Care Property Invest NV was established in 1995 and was incorporated in Belgium.…
Industry Peers
REIT - Healthcare FacilitiesKey Statistics
About Care Property Invest (EBR: CPINV)
›
Care Property Invest (EBR: CPINV) is listed on Euronext Brussels, where its shares trade in EUR. It belongs to the REIT - Healthcare Facilities industry, part of the Real Estate sector, and reports about 22 employees.
The shares were at 12.64 EUR on 20 November 2026, up 17.0% over 52 weeks. Its 52-week range is 10.70 EUR to 14.04 EUR: the price is 10.0% below the high and 18.1% above the low.
At a market capitalisation of 536.02M EUR, it trades at 6.7 times trailing earnings and 11.4 times forward earnings. The median trailing P/E of its 15 largest REIT - Healthcare Facilities peers is 25.6, a discount of 74% for CPINV. It pays a dividend yielding 7.84% (it pays out 53% of its earnings), against a median of 5.64% among the dividend payers in that peer group.
Care Property Invest reports return on equity of 8.4%, an operating margin of 83.3% and revenue up 13.5% year over year.
Its debt exceeds its cash by 666.55M EUR, a debt-to-equity ratio of 0.95. Its Piotroski F-score is 4 out of 9, an average reading of its financial health. 5 analysts cover the stock, with an average rating of Hold; their mean price target of 13.42 EUR is 6.2% above the current price. The next earnings report is expected on 3 March 2027.